Results 101 to 110 of about 3,126,313 (204)

What's Your Diagnosis? A Case of Extreme Thrombocytosis in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Stephanie F. Anderson   +5 more
wiley   +1 more source

Atypical chronic myeloid leukemia: From diagnosis to molecular features and therapeutic options

open access: yesHemaSphere, Volume 9, Issue 12, December 2025.
ABSTRACT Atypical chronic myeloid leukemia (aCML) is a rare form of myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) overlap disorder characterized by neutrophilic leukocytosis with circulating immature myeloid cells (IMC), frequent hepatosplenomegaly, and poor prognosis with high rates of leukemic transformation.
Alessandra Iurlo   +3 more
wiley   +1 more source

Methylation of TET2, CBL and CEBPA in Ph-negative myeloproliferative neoplasms [PDF]

open access: yes, 2010
A loss-of-function mutation of TET2, CBL and CEBPA has been implicated in the pathogenesis or leukaemic transformation of myeloproliferative neoplasm.
Chim, CS, Fung, TK, Wan, TS, Wong, KF
core   +1 more source

Atypical Myocardial Infarction with Apical Thrombus and Systemic Embolism: A Rare Presentation of Likely JAK2 V617F-Positive Myeloproliferative Neoplasm

open access: yesCase Reports in Oncological Medicine, 2020
A few types of myeloproliferative neoplasms may be significant for Janus-associated kinase 2 mutation, JAK2 V617F, including polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Muhammed Atere   +4 more
doaj   +1 more source

Multiple venous and arterial thromboses of the gallbladder causing acute cholecystitis. A previously undescribed complication of essential thrombocythemia(†)(†)Supported in part by Fundación Clínica Médica Sur.

open access: yesAnnals of Hepatology, 2011
Well established complications of essential thrombocythemia are multiple thrombohemorrhagic phenomena in various abdominal organs. We describe the case of a 22 year old man with essential thrombocythemia and thrombosis of the mesenteric and splenic veins
Gabriela Picón-Coronel   +3 more
doaj   +1 more source

Outcomes of Cerebral Venous Thrombosis in Patients With Myeloproliferative Neoplasms from a U.S. Nationwide Hospitalization Study

open access: yes
eJHaem, Volume 7, Issue 1, February 2026.
Nikhil Vojjala   +6 more
wiley   +1 more source

Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis [PDF]

open access: yes, 2010
Aims: To evaluate the feasibility of the histopathological diagnosis of prefibrotic–early primary myelofibrosis (PM) as described in the World Health Organization (WHO) classification and to evaluate the clinical implications of prefibrotic–early PM in a
E. Parot-Schinkel   +5 more
core   +3 more sources

Essential Thrombocythemia Complicated by Addison's Disease: A Case of Overlapping Endocrine and Hematological Disorders

open access: yesHematology, Transfusion and Cell Therapy
This case report delves into the intricacies of managing a patient diagnosed with both essential thrombocythemia and Addison's disease, illustrating the challenges and importance of an integrated approach to complex, coexisting conditions.
Meryem SENER   +7 more
doaj   +1 more source

Prognostic factors for thrombosis, myelofibrosis, and leukemia in essential thrombocythemia: a study of 605 patients

open access: yesHaematologica, 2008
Background Essential thrombocythemia is a chronic myeloproliferative disorder; patients with this disorder have a propensity to develop thrombosis, myelofibrosis, and leukemia.Design and Methods We studied 605 patients with essential thrombocythemia ...
Francesco Passamonti   +12 more
doaj   +1 more source

Incidence of venous thromboembolism and use of anticoagulation in hematological malignancies: Critical review of the literature [PDF]

open access: yes, 2018
Venous Thromboembolism (VTE) frequently complicates the course of hematologic malignancies (HM) and its incidence is similar to that observed in high-risk solid tumors.
Annibali, Ombretta   +3 more
core   +2 more sources

Home - About - Disclaimer - Privacy